Chemoinformaics analysis of 4-Hydroxy-3-methoxyphenylacetone
| Molecular Weight | 180.203 | nRot | 3 |
| Heavy Atom Molecular Weight | 168.107 | nRig | 7 |
| Exact Molecular Weight | 180.079 | nRing | 1 |
| Solubility: LogS | -1.128 | nHRing | 0 |
| Solubility: LogP | 0.854 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 27.1075 |
| nHD | 1 | BPOL | 14.6425 |
| QED | 0.767 |
| Synth | 1.805 |
| Natural Product Likeliness | 0.752 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.536 |
| HIA | 0.005 |
| CACO-2 | -4.465 |
| MDCK | 0.0000253 |
| BBB | 0.091 |
| PPB | 0.540719 |
| VDSS | 0.698 |
| FU | 0.267635 |
| CYP1A2-inh | 0.467 |
| CYP1A2-sub | 0.91 |
| CYP2c19-inh | 0.47 |
| CYP2c19-sub | 0.833 |
| CYP2c9-inh | 0.206 |
| CYP2c9-sub | 0.861 |
| CYP2d6-inh | 0.163 |
| CYP2d6-sub | 0.886 |
| CYP3a4-inh | 0.058 |
| CYP3a4-sub | 0.525 |
| CL | 14.601 |
| T12 | 0.888 |
| hERG | 0.033 |
| Ames | 0.029 |
| ROA | 0.154 |
| SkinSen | 0.328 |
| Carcinogencity | 0.117 |
| EI | 0.959 |
| Respiratory | 0.031 |
| NR-Aromatase | 0.016 |
| Antiviral | No |
| Prediction | 0.895465 |